04/26/2024
3:45 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
3:49 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
3:52 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form ARS | |
04/15/2024
4:23 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
6:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
8:46 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/22/2024
3:44 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
11:43 AM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
DISCOVERY CAPITAL MANAGEMENT, LLC / CT (Filed by)
| Form SC 13G/A | |
01/29/2024
7:45 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
4:47 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:30 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:30 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:25 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:00 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:30 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:30 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:00 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
6:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:01 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
4:34 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Boyle Kevin S. Sr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
11:20 AM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
Boyle Kevin S. Sr. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
3:15 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
4:17 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Vieser Jaime (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:22 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:23 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:24 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hofmeister Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:27 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Postma Robert W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
6:31 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
6:09 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
